Levels of endocannabinoid metabolizing enzymes are not related with BDNF levels in patients with schizophrenia: a case-controlled study
PURPOSE: While the pathogenesis of schizophrenia has yet to be fully clarified, a huge amount of data suggests the involvement of endocannabinoid system and neurotrophic factors in schizophrenia. Nevertheless, only a very limited number of studies have investigated these two systems together. With t...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Mesut Çetin
2019-10-01
|
| coleção: | Psychiatry and Clinical Psychopharmacology |
| Assuntos: | |
| Acesso em linha: | http://dx.doi.org/10.1080/24750573.2018.1540200 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|